Q2 2021 Kiniksa Pharmaceuticals Ltd Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Kiniksa Pharmaceuticals Second Quarter 2021 Financial Results Conference Call. (Operator Instructions)
I would now like to hand the conference over to your host, Rachel Frank. Please go ahead.
Thank you, operator. Good morning, and thank you for joining Kiniksa's call to discuss our Second Quarter 2021 Financial Results and our recent Corporate and Pipeline Activity. A press release highlighting these results can be found on our website under the Investors & Media section.
As for the agenda, our CEO, Sanj K. Patel, will start with an introduction; Ross Moat, our Head of Commercial, will detail our commercial launch; John Paolini, Kiniksa's Chief Medical Officer, will follow with a brief pipeline update, including a review of additional data from our mavrilimumab Phase II clinical trial in COVID-19-related ARDS; Mark Ragosa, our Chief Financial Officer, will review our second quarter 2021 financial results; and finally, Sanj will return for closing remarks and to kick off the Q
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
